Photo of Noura Abul-Husn

Noura Abul-Husn

  • ASSISTANT PROFESSOR Medicine, General Internal Medicine
  • ASSISTANT PROFESSOR Genetics and Genomic Sciences
Print ProfilePrint Profile


  • PhD, Mount Sinai School of Medicine


    Dr. Noura Abul-Husn received her B.Sc. Honors in Life Sciences and M. Sc. in Pharmacology at Queen's University in Canada, and her M.D. and Ph.D. in Biomedical Sciences at the Icahn School of Medicine at Mount Sinai. She completed a combined residency in Internal Medicine and Medical Genetics at Mount Sinai, and served as chief resident in Medical Genetics. She then joined the faculty at Mount Sinai as Assistant Professor in Medicine and in Genetics and Genomic Sciences. She is a member of the Charles Bronfman Institute for Personalized Medicine and the Icahn Institute for Genomics and Multiscale Biology. Dr. Abul-Husn is a practicing clinical geneticist in the Division of Medical Genetics, where her focus is to evaluate adult patients with undiagnosed diseases that have a potential genetic etiology. Her research interests include defining the role of rare genetic variants in common diseases, with the hopes of translating research findings into improved diagnostics and individualized care.

    Click here for lab website.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Abul-Husn during 2015 and/or 2016. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.

  • Regeneron Pharmaceuticals

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central


Annenberg Building Floor 18 Room 80
1468 Madison Avenue
New York, NY 10029